RELMADA THERAPEUTICS, INC. ($RLMD)
Filing Information
| Accession Number | 0001213900-26-098970 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 11, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
200,000
Total Value
$843,990.00
P&L
-3.6% ($29,990.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Sep 9, 2026 | Purchase | 120,200 | $4.20 | $504,840.00 | 920,200 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Sep 10, 2026 | Purchase | 79,800 | $4.25 | $339,150.00 | 1,000,000 | Direct | โ | View Details |